The store will not work correctly when cookies are disabled.
2-((4-(2-amino-4-methoxypyrimidin-5-yl)-1Himidazol-1-yl)methoxy)ethan-1-ol
ID: ALA4796361
PubChem CID: 162676186
Max Phase: Preclinical
Molecular Formula: C11H15N5O3
Molecular Weight: 265.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1nc(N)ncc1-c1cnn(COCCO)c1
Standard InChI: InChI=1S/C11H15N5O3/c1-18-10-9(5-13-11(12)15-10)8-4-14-16(6-8)7-19-3-2-17/h4-6,17H,2-3,7H2,1H3,(H2,12,13,15)
Standard InChI Key: HNCSVAILHNXLJG-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
5.0544 -2.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0533 -3.3990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7613 -3.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4710 -3.3985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4682 -2.5759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7595 -2.1706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3438 -3.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5975 -3.4755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0502 -4.0824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4583 -4.7905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2577 -4.6211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1254 -5.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3126 -5.6216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9797 -6.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1669 -6.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8340 -7.1991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1743 -2.1646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3466 -2.1711 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3464 -1.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
2 7 1 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
5 17 1 0
1 18 1 0
18 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.27 | Molecular Weight (Monoisotopic): 265.1175 | AlogP: -0.10 | #Rotatable Bonds: 6 |
Polar Surface Area: 108.31 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.54 | CX LogP: -0.22 | CX LogD: -0.22 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.70 | Np Likeness Score: -0.96 |
References
1. Thames JE,Waters CD,Valle C,Bassetto M,Aouadi W,Martin B,Selisko B,Falat A,Coutard B,Brancale A,Canard B,Decroly E,Seley-Radtke KL. (2020) Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro., 28 (22): [PMID:33128910] [10.1016/j.bmc.2020.115713] |